Bristol-Myers Squibb Company
TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS

Abstract:

Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, ##STR00001## are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.